These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2801784)

  • 21. Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa.
    Neild GH; Lee HA
    Postgrad Med J; 1977 Jul; 53(621):382-7. PubMed ID: 18728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis.
    Oredugba O; Mazumdar DC; Meyer JS; Lubowitz H
    Ann Intern Med; 1980 Apr; 92(4):504-6. PubMed ID: 7362154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases.
    Moorthy AV; Zimmerman SW; Burkholder PM; Harrington AR
    Clin Nephrol; 1976 Jul; 6(1):319-25. PubMed ID: 782751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
    Zäuner I; Bach D; Braun N; Krämer BK; Fünfstück R; Helmchen U; Schollmeyer P; Böhler J
    Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylprednisolone and cyclophosphamide pulse therapy in crescentic glomerulonephritis: safety and effectiveness.
    Rondeau E; Kourilsky O; Peraldi MN; Alberti C; Kanfer A; Sraer JD
    Ren Fail; 1993; 15(4):495-501. PubMed ID: 8210561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone.
    Fort JG; Abruzzo JL
    Arthritis Rheum; 1988 Sep; 31(9):1194-8. PubMed ID: 3422017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis.
    Sharma P; Kuperman M; Racusen L; Geetha D
    Am J Kidney Dis; 2012 Jul; 60(1):157-9. PubMed ID: 22398109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis.
    Kunis CL; Kiss B; Williams G; D'Agati V; Appel GB
    Clin Nephrol; 1992 Jan; 37(1):1-7. PubMed ID: 1541058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-GBM glomerulonephritis and RPGN].
    Shimizu Y; Tomino Y
    Nihon Jinzo Gakkai Shi; 2009; 51(2):94-7. PubMed ID: 19378793
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid recovery of renal function after pulse steroid therapy in a human immunodeficiency virus-infected patient with glomerulonephritis.
    Gracey D; Garsia R; Britton W; McKenzie P
    Intern Med J; 2012 Dec; 42(12):1363-5. PubMed ID: 23253003
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-dosage heparin in rapidly progressive glomerulonephritis.
    Fye KH; Hancock D; Moutsopoulos H; Humes HD; Arieff AI
    Arch Intern Med; 1976 Sep; 136(9):995-9. PubMed ID: 962457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crescentic glomerulonephritis in children: a review of 43 cases.
    Srivastava RN; Moudgil A; Bagga A; Vasudev AS; Bhuyan UN; Sundraem KR
    Am J Nephrol; 1992; 12(3):155-61. PubMed ID: 1415376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylprednisolone pulse therapy in two clinical types of crescentic glomerulonephritis.
    Takeda S; Kida H; Yokoyama H; Takazakura E; Kobayashi K
    Intern Med; 1998 Jul; 37(7):585-91. PubMed ID: 9711884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and treatment of rapidly progressive glomerulonephritis. An analysis of 20 cases].
    Cheng HF; Wang HY; Pan JS
    Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):222-5, 254. PubMed ID: 1874090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationships of rapidly progressive glomerulonephritis (RPGN), crescentic glomerulonephritis and vasculitis: the clinical, histopathological and therapeutic considerations].
    Covic A; Marian D; Florea L; Mititiuc I; Căruntu I; Cotuţiu C; Covic M
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):63-72. PubMed ID: 9455438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
    Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
    Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crescentic glomerulonephritis as renal cause of acute renal failure.
    Grcevska L; Polenakovic M
    Ren Fail; 1995 Sep; 17(5):595-604. PubMed ID: 8570872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA positive interstitial pneumonia].
    Yamazaki K; Kanehira K; Inaba Y; Shimizu J; Sugiyama N
    Nihon Jinzo Gakkai Shi; 2012; 54(8):1203-8. PubMed ID: 23387284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.